Imaging of Lung Cancer in the Era of Molecular Medicine-Reference-Cited by-同舟云学术

Imaging of Lung Cancer in the Era of Molecular Medicine

Published:2011-04 Issue:4 Volume:18 Page:424-436
ISSN:1076-6332
Container-title:Academic Radiology
language:en
Short-container-title:Academic Radiology

Author:

Nishino Mizuki,Jackman David M.,Hatabu Hiroto,Jänne Pasi A.,Johnson Bruce E.,Van den Abbeele Annick D.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging

Reference96 articles.

1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

2. American Cancer Society. Cancer facts and figures, 2009. Available at: http://ww3.cancer.org/downloads/STT/500809web.pdf. Accessed December 22, 2010.

3. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials;BMJ,1995

4. Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results;Breathnach;J Clin Oncol,2001

5. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of 68Ga-FAP-2286 and 18F-FDG PET/CT in the diagnosis of advanced lung cancer;Frontiers in Oncology;2024-07-01

2. State of the Art: Lung Cancer Staging Using Updated Imaging Modalities;Bioengineering;2022-09-22

3. Beyond bone biology: Lessons from team science;Journal of Orthopaedic Research;2020-07-22

4. A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma;Physics in Medicine & Biology;2020-03-06

5. Tumor Volume Analysis as a Predictive Marker for Prolonged Survival in Anaplastic Lymphoma Kinase–rearranged Advanced Non–Small Cell Lung Cancer Patients Treated With Crizotinib;Journal of Thoracic Imaging;2020-03